Rare diseases
Investigational molecules
Locations
Lochhamer Schlag 21, Lochham, 82166, Germany
Immunic AG’s clinical research is centered on multiple sclerosis, with active studies in relapsing multiple sclerosis and relapsing-remitting multiple sclerosis. The programme includes evaluation of disease activity, relapse prevention, and neurological outcomes in adults with active disease.
Clinical interest in this area includes treatment of inflammatory disease activity and control of relapse-related progression.
Immunic AG runs clinical trials in conditions such as Relapsing multiple sclerosis, Relapsing-remitting multiple sclerosis, Progressive multiple sclerosis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BulgariaBulgaria
EstoniaBulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
